CPSE:BAVABiotechs
Why Bavarian Nordic (CPSE:BAVA) Climbed After Its Latest Update
Bavarian Nordic (CPSE:BAVA) has drawn fresh attention after reporting second quarter 2026 results, raising full year revenue guidance to about DKK 5,700 million and completing a DKK 500 million share buyback program.
The latest results and guidance upgrade come after a strong short term rebound in Bavarian Nordic's share price, with a 7 day share price return of 15.45% and a 30 day share price return of 25.11%. However, the 1 year total shareholder return is down 8.7% and the 5 year total...